Trial Outcomes & Findings for Feasibility of Endovascular Repair of Ascending Aortic Pathologies (NCT NCT03322033)

Last Updated: 2026-03-02

Results Overview

Number of participants with freedom from early death at 30-days post-procedure

Recruitment status

TERMINATED

Study phase

Target enrollment

1 participants

Primary outcome timeframe

30 days

Results posted on

2026-03-02

Participant milestones
Measure	Type A Dissection High risk subjects with ascending thoracic aortic pathologies including type A aortic dissection who are suitable for endovascular repair Valiant PS-IDE Stent Graft: Medtronic Valiant PS-IDE Stent Graft System with the Captivia Delivery System
Overall Study STARTED	1
Overall Study COMPLETED	0
Overall Study NOT COMPLETED	1

Reasons for withdrawal
Measure	Type A Dissection High risk subjects with ascending thoracic aortic pathologies including type A aortic dissection who are suitable for endovascular repair Valiant PS-IDE Stent Graft: Medtronic Valiant PS-IDE Stent Graft System with the Captivia Delivery System
Overall Study Adverse Event	1

Feasibility of Endovascular Repair of Ascending Aortic Pathologies

Baseline characteristics by cohort
Measure	Type A Dissection n=1 Participants High risk subjects with ascending thoracic aortic pathologies including type A aortic dissection who are suitable for endovascular repair Valiant PS-IDE Stent Graft: Medtronic Valiant PS-IDE Stent Graft System with the Captivia Delivery System
Age, Categorical <=18 years	0 Participants n=41 Participants
Age, Categorical Between 18 and 65 years	0 Participants n=41 Participants
Age, Categorical >=65 years	1 Participants n=41 Participants
Sex: Female, Male Female	1 Participants n=41 Participants
Sex: Female, Male Male	0 Participants n=41 Participants
Race (NIH/OMB) American Indian or Alaska Native	0 Participants n=41 Participants
Race (NIH/OMB) Asian	0 Participants n=41 Participants
Race (NIH/OMB) Native Hawaiian or Other Pacific Islander	0 Participants n=41 Participants
Race (NIH/OMB) Black or African American	0 Participants n=41 Participants
Race (NIH/OMB) White	1 Participants n=41 Participants
Race (NIH/OMB) More than one race	0 Participants n=41 Participants
Race (NIH/OMB) Unknown or Not Reported	0 Participants n=41 Participants
Ethnicity (NIH/OMB) Hispanic or Latino	0 Participants n=41 Participants
Ethnicity (NIH/OMB) Not Hispanic or Latino	1 Participants n=41 Participants
Ethnicity (NIH/OMB) Unknown or Not Reported	0 Participants n=41 Participants
Region of Enrollment United States	1 participants n=41 Participants

Timeframe: 30 days

Number of participants with freedom from early death at 30-days post-procedure

Outcome measures
Measure	Type A Dissection n=1 Participants High risk subjects with ascending thoracic aortic pathologies including type A aortic dissection who are suitable for endovascular repair Valiant PS-IDE Stent Graft: Medtronic Valiant PS-IDE Stent Graft System with the Captivia Delivery System
Number of Participants With Freedom From Early Death	1 Participants

Serious events: 1 serious events

Other events: 0 other events

Deaths: 0 deaths

Serious adverse events
Measure	Type A Dissection n=1 participants at risk High risk subjects with ascending thoracic aortic pathologies including type A aortic dissection who are suitable for endovascular repair Valiant PS-IDE Stent Graft: Medtronic Valiant PS-IDE Stent Graft System with the Captivia Delivery System
Surgical and medical procedures Type 1B endoleak	100.0% 1/1 • Number of events 1 • 1 year

Adverse event data not reported

Baylor Scott and White Resarch Institute

Phone: 469-814-4845